Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

Sodium butyrate inhibits high glucose-induced inflammation by controlling the acetylation of NF-κB p65 in human monocytes

(2023) Ha-Rin Moon et al.   Nutrition Research and Practice

The effect of short-chain fatty acids on M2 macrophages polarization in vitro and in vivo

(2022) Chunrong Huang et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats

(2022) Jing Mao et al.   International Journal of Chronic Obstructive Pulmonary Disease

The Emerging Role of Macrophages in Chronic Obstructive Pulmonary Disease: The Potential Impact of Oxidative Stress and Extracellular Vesicle on Macrophage Polarization and Function

(2022) Mauro Finicelli et al.   Antioxidants

Pathological Mechanism and Targeted Drugs of COPD

(2022) Peng Guo et al.   International Journal of Chronic Obstructive Pulmonary Disease

Acetate, a gut bacterial product, ameliorates ischemia-reperfusion induced acute lung injury in rats

(2022) Kuei-Yi Hung et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Natural history and mechanisms of COPD

(2021) Peter Lange et al.   RESPIROLOGY

Nuclear factor-kappa B and its role in inflammatory lung disease

(2021) Khalid Saad Alharbi et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway

(2021) Yanglin Wu et al.   JOURNAL OF NANOBIOTECHNOLOGY

Roles of Inflammasome in Cigarette Smoke-Related Diseases and Physiopathological Disorders: Mechanisms and Therapeutic Opportunities

(2021) Yiming Ma et al.   Frontiers in Immunology

Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade

(2021) Davies Adeloye et al.   Journal of Global Health

Lung Macrophage Functional Properties in Chronic Obstructive Pulmonary Disease

(2020) Kentaro Akata et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

NLRP3 Inflammasome—A Key Player in Antiviral Responses

(2020) Chunyuan Zhao et al.   Frontiers in Immunology

Goals of COPD treatment: Focus on symptoms and exacerbations

(2020) Claus F. Vogelmeier et al.   RESPIRATORY MEDICINE

Sodium butyrate promotes lipopolysaccharide-induced innate immune responses by enhancing mitogen-activated protein kinase activation and histone acetylation in bovine mammary epithelial cells

(2020) Hongyu Dai et al.   JOURNAL OF DAIRY SCIENCE

Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3

(2020) Marion Lenoir et al.   Gut Microbes

Sodium butyrate protects against lipopolysaccharide-induced liver injury partially via the GPR43/ β-arrestin-2/NF-κB network

(2020) Qian-Jiang Luo et al.   Gastroenterology Report

Sodium Butyrate Inhibits the Inflammation of LPS-induced Acute Lung Injury in Mice by Regulating the TLR4/NF-κB Signaling Pathway

(2019) Jing Liu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies

(2019) Stanley M.H. Chan et al.   PHARMACOLOGY & THERAPEUTICS

Butyrate ameliorates caerulein‐induced acute pancreatitis and associated intestinal injury by tissue specific mechanisms

(2019) Xiaohua Pan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke

(2019) Mari Hikichi et al.   Journal of Thoracic Disease

Biologic Drugs: A New Target Therapy in COPD?

(2018) Ahmed Yousuf et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease

(2018) Huaying Wang et al.   INFLAMMATION

Sodium butyrate alleviates LPS-induced acute lung injury in mice via inhibiting HMGB1 release

(2018) Na Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells

(2018) Camille Martin-Gallausiaux et al.   Scientific Reports

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects

(2018) KEC Bouter et al.   Clinical and Translational Gastroenterology

Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model

(2018) Guangxin Chen et al.   EBioMedicine

Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner

(2017) Changhyun Lee et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells

(2017) A. Elce et al.   Beneficial Microbes

Inflammatory mechanisms in patients with chronic obstructive pulmonary disease

(2016) Peter J. Barnes   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis

(2016) Sathish Sivaprakasam et al.   PHARMACOLOGY & THERAPEUTICS

Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways

(2015) Mahesh Sapkota et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation

(2014) E.C. Aguilar et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

β-Arrestin 2 Mediates G Protein-Coupled Receptor 43 Signals to Nuclear Factor-κB

(2013) Su Ui Lee et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC

(2013) V Sagulenko et al.   CELL DEATH AND DIFFERENTIATION

Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in Mice

(2013) Myung H. Kim et al.   GASTROENTEROLOGY

Correction: Cigarette Smoke Induced Airway Inflammation Is Independent of NF-κB Signalling

(2013) Joseph M. D. Rastrick et al.   PLoS One

Pathogenesis of chronic obstructive pulmonary disease

(2012) Rubin M. Tuder et al.   JOURNAL OF CLINICAL INVESTIGATION

Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: To establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease

(2012) Yi-Chu Nie et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Role of matrix metalloproteinases in the inflammatory process of respiratory diseases

(2009) Vincent Lagente et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY